(Q39607444)

English

Immunization with DnaJ (hsp40) could elicit protection against nasopharyngeal colonization and invasive infection caused by different strains of Streptococcus pneumoniae

scientific article published on 14 January 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 September 2017

Immunization with DnaJ (hsp40) could elicit protection against nasopharyngeal colonization and invasive infection caused by different strains of Streptococcus pneumoniae (English)

1 reference

Europe PubMed Central

13 September 2017

0 references

Streptococcus pneumoniae

1 reference

based on heuristic

inferred from title

invasive infection

1 reference

based on heuristic

inferred from title

author name string

Yali Cui

1

1 reference

Europe PubMed Central

13 September 2017

Xuemei Zhang

2

1 reference

Europe PubMed Central

13 September 2017

Yi Gong

3

1 reference

Europe PubMed Central

13 September 2017

Siqiang Niu

4

1 reference

Europe PubMed Central

13 September 2017

Nanlin Yin

5

1 reference

Europe PubMed Central

13 September 2017

Run Yao

6

1 reference

Europe PubMed Central

13 September 2017

Wenchun Xu

7

1 reference

Europe PubMed Central

13 September 2017

Dairong Li

8

1 reference

Europe PubMed Central

13 September 2017

Hong Wang

9

1 reference

Europe PubMed Central

13 September 2017

Yujuan He

10

1 reference

Europe PubMed Central

13 September 2017

Ju Cao

11

1 reference

Europe PubMed Central

13 September 2017

Yibing Yin

12

1 reference

Europe PubMed Central

13 September 2017

language of work or name

0 references

publication date

14 January 2011

1 reference

Europe PubMed Central

13 September 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

13 September 2017

29

1 reference

Europe PubMed Central

13 September 2017

9

1 reference

Europe PubMed Central

13 September 2017

1736-1744

1 reference

Europe PubMed Central

13 September 2017

Invasive pneumococcal disease and the potential for prevention by vaccination in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Preventability of invasive pneumococcal disease and assessment of current polysaccharide vaccine recommendations for adults: United States, 2001-2003

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Mucosal immunization with polyamine transport protein D (PotD) protects mice against nasopharyngeal colonization with Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

The clinical effectiveness of pneumococcal vaccination: a brief review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Immunogenicity of pneumococcal conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Emergence of nonvaccine serotypes following introduction of pneumococcal conjugate vaccine: cause and effect?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Novel vaccine strategies with protein antigens of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Immunogenicity and protective efficacy of DnaJ (hsp40) of Streptococcus pneumoniae against lethal infection in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Streptococcus pneumoniae colonisation: the key to pneumococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Emergence of vancomycin tolerance in Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Caseinolytic protease: a protein vaccine which could elicit serotype-independent protection against invasive pneumococcal infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Prevention of pneumococcal disease by vaccination: does serotype replacement matter?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Vaccine escape recombinants emerge after pneumococcal vaccination in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Four antibiotic-resistant Streptococcus pneumoniae clones unrelated to the pneumococcal conjugate vaccine serotypes, including 2 new serotypes, causing acute otitis media in southern Israel

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Pneumococcal vaccines: an update on current strategies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Pneumococcal conjugate vaccines: proceedings from an interactive symposium at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Genetic diversity of pneumococcal surface protein A of Streptococcus pneumoniae meningitis in German children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Role of heat shock proteins in protection from and pathogenesis of infectious diseases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Structure, function and evolution of DnaJ: conservation and adaptation of chaperone function

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Streptococcus pneumoniae: proteomics of surface proteins for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Establishment of a Streptococcus pneumoniae nasopharyngeal colonization model in adult mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Pneumococcal carriage results in ganglioside-mediated olfactory tissue infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Hsp70: a carrier molecule with built-in adjuvanticity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Mucosal immunization with purified ClpP could elicit protective efficacy against pneumococcal pneumonia and sepsis in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Streptococcus pneumoniae surface-exposed glutamyl tRNA synthetase, a putative adhesin, is able to induce a partially protective immune response in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

CD4(+) T lymphocytes mediated protection against invasive pneumococcal infection induced by mucosal immunization with ClpP and CbpA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Optimized immune response elicited by a DNA vaccine expressing pneumococcal surface protein a is characterized by a balanced immunoglobulin G1 (IgG1)/IgG2a ratio and proinflammatory cytokine production

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Identification of Streptococcus pneumoniae genes specifically induced in mouse lung tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Construction and evaluation of new drug-resistance cassettes for gene disruption mutagenesis in Streptococcus pneumoniae, using an ami test platform.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Live attenuated Streptococcus pneumoniae strains induce serotype-independent mucosal and systemic protection in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Global transcriptional analysis of clpP mutations of type 2 Streptococcus pneumoniae and their effects on physiology and virulence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Regulation of the heat-shock protein 70 reaction cycle by the mammalian DnaJ homolog, Hsp40.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

The diversity of the DnaJ/Hsp40 family, the crucial partners for Hsp70 chaperones

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Intestinal IgA: novel views on its function in the defence of the largest mucosal surface.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.126

7 January 2021

Identifiers

10.1016/J.VACCINE.2010.12.126

1 reference

Europe PubMed Central

13 September 2017

1 reference

Europe PubMed Central

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39607444&oldid=2056383531"